Latest News

FDA approval seal -- Image credit: Aquir |
FDA Approves Dolutegravir/Lamivudine for Treatment of Adolescents With HIV-1 Infection

April 8th 2024

The treatment is indicated for adolescents at least 12 years of age who weigh at least 25 kg without a previous treatment history of antiretroviral therapies.

Acute lymphoblastic leukemia -- Image credit: Dr_Microbe |
Study Finds ALL Genetic Variant That Indicates Why Hispanic, Pediatric Patients Are Likely to Develop Disease

March 29th 2024

Health care worker with model of pancreas -- Image credit: Jo Panuwat D |
New Research Shows Impact, Efficacy of PERT in Pediatric Patients With Pancreatitis

March 28th 2024

U.S. Food and Drug Administration FDA approved vector stamp | Image Credit: Calin -
FDA Approves Givinostat as First Nonsteroidal Drug for Duchenne Muscular Dystrophy

March 22nd 2024

Concept of FDA Food and Drug Administration | Image Credit: wladimir1804 -
FDA Approves Rilpivirine for Treatment of HIV for Pediatric Patients 2 and Older

March 21st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.